Nucleofill SOFT PLUS Eyes is an innovative preparation intended for use on the very delicate eye area. Thanks to the content of purified polynucleotides of natural origin, it perfectly nourishes and cares for the skin in this area. It has a moisturizing, antioxidant and anti-radical effect. It stimulates the growth of fibroblasts, giving a lifting effect.
Purified polynucleotides simulate skin bioregeneration processes, both at the level of the dermis (fibroblasts) and at the level of adipose and bone tissue. The natural composition eliminates the risk of allergies in the patient.
Nucleofill Soft Plus works in three areas:
- epidermis and dermis
- subcutaneous tissue
- for use on the eye area
- deep layers of the skin biorestructing
- restoring the skin's firmness
- reduction of fine wrinkles around the eyes, the so-called crow's feet
- dark circles under the eyes
- lowering the browbone
- anti-aging prophylaxis
- dry skin, exposed to oxidative stress
- allergy to the ingredients of the preparation
- fatty tissue overgrowth around the lower eyelid (fat sacs)
- swelling of the lower eyelids
- skin inflammations, including cold sores
- circulatory diseases
- diabetes, epilepsy, severe allergies
- pregnancy and breastfeeding
- age under 18
Directions for use:
According to the manufacturer's recommendations, Nucleofill Soft Plus should be administered using the microdeposit technique, approximately 0.05 ml for each of them, keeping a 0.5 cm gap between one deposit and the other. In order to maintain the effects, one administration every three months is recommended.
Treatments with Nucleofill Soft Plus can be combined with other treatments in the field of aesthetic medicine, i.e. botulinum toxin, PQ Age Evolution, bleferoplasty and plasma treatments, and revitalization treatments.
- Polymerized polynucleotides (PDRN) 7.5 mg / ml
- 1 pre-filled syringe 2 ml,
- two needles 30Gx13 mm
Product for professional use only.
By deciding to purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine.